Tpg Gp A »

Halozyme Therapeutics shares owned by Tpg Gp A

Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Tpg Gp A from 13F filings

Historical chart of Tpg Gp A investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Tpg Gp A consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Tpg Gp A

Quarter filed Position value Share count Share price at filing
2026-03-31 $10M 10M 1.04

More positions owned by Tpg Gp A

Lifestance Health Group (LFST)
Jackson Financial Com Cl A (JXN)
Life Time Group Holdings Common Stock (LTH)
Sionna Therapeutics (SION)
Beta Technologies Com Shs Cl A (BETA)
Amneal Pharmaceuticals Com Stk Cl A (AMRX)
Ngl Energy Partners Com Unit Repst (NGL)
Ceribell (CBLL)
Harsco Corporation (NVRI)
Bofa Fin MTNF 0.600% 5/2
Bicara Therapeutics (BCAX)
Evergy Note 4.500%12/1
Starwood Ppty Tr Note 6.750% 7/1
Bruker Corp 6.375 Pref Ser A (BRKRP)
Allogene Therapeutics (ALLO)

View all positions for Tpg Gp A

Top funds holding Halozyme Therapeutics

M&G
Citadel Advisors
Steelhead Partners
Nuveen
Silverback Asset Management
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Citigroup
Tpg Gp A
Angelo, Gordon & Co
Point72 Asset Management
Balyasny Asset Management
Calamos Advisors
MacKay Shields
Colony
Water Island Capital

View all funds holding Halozyme Therapeutics